TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2403730

Group type: COMPARATOR
Intervention: Non-Q-wave AMI
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Progression to Q-wave AMI
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Progression to Q-wave AMI within 48 hours
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Progression to Q-wave AMI after 48 hours
Number of subjects: 544
Study: 344157

Group type: EXPERIMENTAL
Intervention: Cimetidine 300 mg four times daily
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg four times daily
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 30122911

Group type: EXPERIMENTAL
Intervention: Liuzijue exercise group (LG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison between LG and CG
Number of subjects: 40
Study: 26997377

Group type: EXPERIMENTAL
Intervention: Nutritional education for 12 weeks
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 99
Study: 25120315

Group type: EXPERIMENTAL
Intervention: Sirolimus (SRL) conversion from calcineurin inhibitors (CNI)
Number of subjects: 45
Study: 23194491

Group type: EXPERIMENTAL
Intervention: Paricalcitol (2 μg oral)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study: 20184605

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) for grass pollen; specific details on dosage and duration not provided.
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo treatment; specific details on dosage and duration not provided.
Number of subjects: 31
Study: 19192804

Group type: EXPERIMENTAL
Intervention: Diesel exhaust (DE) exposure at approximately 100 microg/m3
Number of subjects: 0

Group type: COMPARATOR
Intervention: Purified air
Number of subjects: 0
Study: 15785883

Group type: EXPERIMENTAL
Intervention: Cefoxitin (100 mg) added to Tisseel-VH fibrin sealant
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Surgical closure of the primary opening
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Combined treatment (Cefoxitin + Surgical closure)
Number of subjects: 75
Study: 14728086

Group type: COMPARATOR
Intervention: Oral ziprasidone
Number of subjects: 0
Study: 10532523

Group type: EXPERIMENTAL
Intervention: Nitroglycerin lingual spray
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nitroglycerin sublingual tablet
Number of subjects: 0
Study: 8889304

Group type: EXPERIMENTAL
Intervention: Cetirizine
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Histamine (control)
Number of subjects: 9
Study: 1909749

Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin (TN)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Long-acting oral nitrates (LAON)
Number of subjects: 112
Study: 6344297

Group type: EXPERIMENTAL
Intervention: Proximal gastric vagotomy without drainage (PGV)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Selective vagotomy, antrectomy, and gastroduodenostomy (SVA)
Number of subjects: 40
Study: 3859027

Group type: EXPERIMENTAL
Intervention: Preventive measures focused on oral hygiene and/or fluorides
Number of subjects: 95
Study: 31118485

Group type: EXPERIMENTAL
Intervention: 3-month intervention involving a face-to-face meeting (medication review and consumer-centred video) and health coaching every two weeks
Number of subjects: 71

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 71
Study: 30033445

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 341

Group type: COMPARATOR
Intervention: Observation arm
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Vitamin D levels
Number of subjects: 341
Study: 27416546

Group type: EXPERIMENTAL
Intervention: Topical furosemide (300 µg per day, 2 puffs twice a day for 2 months)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 25152604

Group type: EXPERIMENTAL
Intervention: Herb-partitioned moxibustion combined with acupuncture
Number of subjects: 92

Group type: COMPARATOR
Intervention: Wheat bran-partitioned moxibustion combined with superficial acupuncture
Number of subjects: 92
Study: 21994026

Group type: EXPERIMENTAL
Intervention: Acupuncture with manual manipulation (manipulation group)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Acupuncture without manipulation (non-manipulation group)
Number of subjects: 120
Study: 20493474

Group type: EXPERIMENTAL
Intervention: 17β‐E2 1 mg/drospirenone 2 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: 17β‐E2 1 mg/norethisterone acetate 0.5 mg
Number of subjects: 100
Study: 18634941

Group type: EXPERIMENTAL
Intervention: Mechanical debridement (scaling and root planing)
Number of subjects: 67
Study: 15616757

Group type: EXPERIMENTAL
Intervention: I.M. testovirone depot 100 mg monthly for 6 months
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Oxandrolone 5 mg/m2 daily for 6 months
Number of subjects: 45

Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 45
Study: 14499778

Group type: EXPERIMENTAL
Intervention: Prototype wide angle colonoscope
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard colonoscope
Number of subjects: 70
Study: 10941955

Group type: EXPERIMENTAL
Intervention: Feedback on asthma treatment
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Feedback on UTI treatment
Number of subjects: 24
Study: 8814852

Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Dihydrotestosterone (DHT)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Sexual-hormone binding globulin (SHBG)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Prostate specific antigen (PSA)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Testosterone/DHT ratio
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Regression analysis on T-stage, PSA level and DHT
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Multivariate analysis
Number of subjects: 195
Study: 1533266

Group type: EXPERIMENTAL
Intervention: Weight-Belt (WB)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Without Belt (WOB)
Number of subjects: 5
Study: 6376291

Group type: EXPERIMENTAL
Intervention: 5FU and methyl CCNU
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no early treatment)
Number of subjects: 52
Study: 30726394

Group type: EXPERIMENTAL
Intervention: Bolsa Família Programme (PBF)
Number of subjects: 1133

Group type: EXPERIMENTAL
Intervention: Family Health Strategy (FHS)
Number of subjects: 1133
Study: 27003392

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 27513246

Group type: EXPERIMENTAL
Intervention: Migraineurs (n=998)
Number of subjects: 2001

Group type: COMPARATOR
Intervention: Nonmigraineurs (n=1003)
Number of subjects: 2001

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 2001
Study: 25129884

Group type: EXPERIMENTAL
Intervention: Rosa damascene aromatherapy for three subsequent nights
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 60
Study: 22624890

Group type: EXPERIMENTAL
Intervention: Anterior stromal pocket hydration
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional hydration
Number of subjects: 48
Study: 20553645

Group type: EXPERIMENTAL
Intervention: Olopatadine 0.1 %
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ketotifen 0.025 %
Number of subjects: 40
Study: 18055312

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 15084997

Group type: EXPERIMENTAL
Intervention: Nursery staff advice and modeling of infant sleep positioning
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Exclusive supine infant placement advice from nursery staff
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Supine infant placement by mothers
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Nursery staff placement practices
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Maternal race/ethnicity
Number of subjects: 675
Study: 12236280

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10357489

Group type: COMPARATOR
Intervention: Metal stent palliation in biliary malignant obstruction (132 patients)
Number of subjects: 4753

Group type: COMPARATOR
Intervention: Metal stent palliation in esophageal malignant obstruction (82 patients)
Number of subjects: 4753
Study: 9082830

Group type: EXPERIMENTAL
Intervention: Microvessel count (MC) assessed using JC70 monoclonal antibody (CD31)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Microvessel count (MC)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 68
Study: 1796618

Group type: EXPERIMENTAL
Intervention: Plasma exchange
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prednisolone-pulse-therapy
Number of subjects: 0
Study: 6828842

Group type: EXPERIMENTAL
Intervention: Acetazolamide (2 X 250 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Long-term Acetazolamide therapy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Untreated patients
Number of subjects: 14
Study: 31512954

Group type: EXPERIMENTAL
Intervention: Nomogram model for prognosis
Number of subjects: 0
Study: 29452244

Group type: EXPERIMENTAL
Intervention: Saline enema
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 100
Study: 26254255

Group type: EXPERIMENTAL
Intervention: rTMS combined with comprehensive rehabilitation therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham therapy combined with comprehensive rehabilitation therapy
Number of subjects: 30
Study: 25682193

Group type: EXPERIMENTAL
Intervention: Unannounced hand hygiene reminder signs
Number of subjects: 237

Group type: COMPARATOR
Intervention: No signs (control)
Number of subjects: 237
Study: 23833270

Group type: EXPERIMENTAL
Intervention: (11)C-tariquidar
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: (11)C-elacridar
Number of subjects: 11
Study: 20068585

Group type: EXPERIMENTAL
Intervention: Recommended dairy weight maintenance diet
Number of subjects: 113

Group type: COMPARATOR
Intervention: Low dairy weight maintenance diet
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Both diets (recommended and low dairy)
Number of subjects: 113
Study: 18251624

Group type: EXPERIMENTAL
Intervention: Olanzapine (2.5-15 mg/day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 16644326

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent
Number of subjects: 101

Group type: COMPARATOR
Intervention: Bare stent (historical control)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Cypher stent (historical control)
Number of subjects: 101
Study: 12527154

Group type: EXPERIMENTAL
Intervention: Multimodal patient education program with cognitive‐behavioral stress management training
Number of subjects: 68

Group type: COMPARATOR
Intervention: Education program without stress management (Control)
Number of subjects: 68
Study: 11008913

Group type: EXPERIMENTAL
Intervention: HPV testing
Number of subjects: 2098

Group type: COMPARATOR
Intervention: Cytology
Number of subjects: 2098

Group type: EXPERIMENTAL
Intervention: Combination of HPV and LSIL cutpoint
Number of subjects: 2098
Study: 9199541

Group type: EXPERIMENTAL
Intervention: linoleic acid (18:2)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: oleic acid (cis‐18:1)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: trans fatty acids (trans‐18:1)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: stearic acid (18:0)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: palmitic acid (16:0)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: myristic acid (14:0)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: mixture of saturated fatty acids (12:0, 14:0, and 16:0)
Number of subjects: 232
Study: 1286716

Group type: EXPERIMENTAL
Intervention: Day case surgery
Number of subjects: 442

Group type: COMPARATOR
Intervention: Inpatient surgery
Number of subjects: 442
Study: 3884297

Group type: EXPERIMENTAL
Intervention: Photocoagulation (N = 73)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Injection sclerotherapy with phenol (N = 62)
Number of subjects: 135
Study: 29754402

Group type: EXPERIMENTAL
Intervention: High MAP (70-80 mm Hg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Low MAP (40-50 mm Hg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High MAP (70-80 mm Hg) for sm AV (<20 μm)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Low MAP (40-50 mm Hg) for sm AV (<20 μm)
Number of subjects: 36
Study: 27916080

Group type: EXPERIMENTAL
Intervention: Preservation of left colonic artery (LCA)
Number of subjects: 97

Group type: COMPARATOR
Intervention: No preservation of left colonic artery (LCA)
Number of subjects: 97
Study: 24155093

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (SB) supplementation at 0.3 g/kg body mass
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (SB) supplementation
Number of subjects: 21
Study: 22473067

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 0
Study: 20362910

Group type: EXPERIMENTAL
Intervention: Prediction method using mandibular right first molar and lateral incisor, and maxillary left central incisor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New prediction method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other methods from the literature
Number of subjects: 0
Study: 18408607

Group type: COMPARATOR
Intervention: CHO (0.8 g.kg(‐1)h(‐1) of carbohydrate)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: CHO‐PRO (0.8 g.kg(‐1)h(‐1) of carbohydrate + 0.3 g.kg(‐1)h(‐1) of whey protein isolate)
Number of subjects: 6
Study: 16161728

Group type: EXPERIMENTAL
Intervention: Levo‐alpha‐acetylmethadol (LAAM) treatment
Number of subjects: 64

Group type: COMPARATOR
Intervention: Community treatment referral information only (Control)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Withdrawn from treatment (Control)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control and Withdrawn groups
Number of subjects: 64
Study: 14620393

Group type: EXPERIMENTAL
Intervention: Erythropoietin therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blood transfusions
Number of subjects: 0
Study: 10992613

Group type: EXPERIMENTAL
Intervention: Applied relaxation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitrous oxide sedation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 8777484

Group type: EXPERIMENTAL
Intervention: Intravenous propafenone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chronic oral administration of propafenone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 0
Study: 8204338

Group type: EXPERIMENTAL
Intervention: Counselling (brief psychotherapy)
Number of subjects: 0
Study: 3294945

Group type: EXPERIMENTAL
Intervention: Topical minoxidil 2% solution applied twice daily with UVB treatment
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Topical minoxidil 2% solution applied twice daily with PUVA treatment
Number of subjects: 9

Group type: COMPARATOR
Intervention: Topical minoxidil 2% solution applied twice daily without UVL
Number of subjects: 9
Study: 29649309

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir monotherapy (MT)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Triple therapy (TT)
Number of subjects: 225
Study: 27184917

Group type: EXPERIMENTAL
Intervention: Pediatric Measure of Participation (PMoP) short forms
Number of subjects: 703
Study: 26009977

Group type: EXPERIMENTAL
Intervention: Clinical Decision Support (CDS) intervention
Number of subjects: 7919

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 7919
Study: 24041682

Group type: EXPERIMENTAL
Intervention: Moderate-intensity endurance-type exercise (45 min, ∼6 METs)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Activities of daily living (3 bouts of 15 min, ∼3 METs)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sedentary control condition
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Moderate-intensity endurance-type exercise
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Activities of daily living
Number of subjects: 20
Study: 21068191

Group type: EXPERIMENTAL
Intervention: Patient Self-Management (PSM)
Number of subjects: 517

Group type: COMPARATOR
Intervention: Routine Care (RC)
Number of subjects: 517
Study: 19391534

Group type: EXPERIMENTAL
Intervention: Scalp acupuncture with needles retained for 2 hours
Number of subjects: 62

Group type: COMPARATOR
Intervention: Scalp acupuncture with needles retained for 30 minutes (control group)
Number of subjects: 62
Study: 17531401

Group type: EXPERIMENTAL
Intervention: Whole pelvic radiotherapy (WPRT) + Neoadjuvant hormonal therapy (NHT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prostate only radiotherapy (PORT) + Neoadjuvant hormonal therapy (NHT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Whole pelvic radiotherapy (WPRT) + Adjuvant hormonal therapy (AHT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prostate only radiotherapy (PORT) + Adjuvant hormonal therapy (AHT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant hormonal therapy (NHT) + Radiotherapy (RT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whole pelvic radiotherapy (WPRT)
Number of subjects: 0
Study: 15345017

Group type: EXPERIMENTAL
Intervention: Co-Cr + polident
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Co-Cr + manipulation
Number of subjects: 48

Group type: COMPARATOR
Intervention: Co-Cr + water
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ti-6Al-4V + polident
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ti-6Al-4V + manipulation
Number of subjects: 48

Group type: COMPARATOR
Intervention: Ti-6Al-4V + water
Number of subjects: 48
Study: 11220039

Group type: EXPERIMENTAL
Intervention: Integrated service (community-based rehabilitation officer input)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional hospital-based optometric service
Number of subjects: 0

Group type: COMPARATOR
Intervention: Generic community input (non-integrated and not vision specific)
Number of subjects: 0
Study: 10901187

Group type: EXPERIMENTAL
Intervention: Urinary thymidine glycol excretion after kidney transplantation
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Proteinuria levels after kidney transplantation
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Gel-electrophoretic pattern of proteinuria
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Thymidine glycol excretion levels during different phases
Number of subjects: 6
Study: 7706060

Group type: EXPERIMENTAL
Intervention: Supine restraint
Number of subjects: 20

Group type: COMPARATOR
Intervention: Prone restraint
Number of subjects: 20
Study: 2694860

Group type: EXPERIMENTAL
Intervention: Auscultation of the upper abdomen and lungs
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Auscultation of the lungs
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Suction on the tubes with a 60‐ml syringe
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Observation for condensation of water vapor and abnormal movements of the upper abdomen
Number of subjects: 40
Study: 15760

Group type: COMPARATOR
Intervention: Beta-adrenoreceptor antagonists (specific drugs not mentioned)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 31398157

Group type: EXPERIMENTAL
Intervention: No intravenous fluids before surgery (study group, 90 patients)
Number of subjects: 180

Group type: COMPARATOR
Intervention: 500 ml crystalline intravenous fluids one hour before anaesthesia (control group, 90 patients)
Number of subjects: 180
Study: 27485805

Group type: EXPERIMENTAL
Intervention: Rocuronium (0.6mg/kg) injected into a large vein in the antecubital fossa (group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rocuronium (0.6mg/kg) injected into the vein on the dorsum of the hand (group D)
Number of subjects: 60
Study: 25789518

Group type: EXPERIMENTAL
Intervention: Individualized pharmacotherapeutic care plan and diabetes education (Intervention Group)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard care (Control Group)
Number of subjects: 70
Study: 23814850

Group type: EXPERIMENTAL
Intervention: R-CHOP + rIL-2 (1 million IU per day, subcutaneously, days 1-5)
Number of subjects: 109

Group type: COMPARATOR
Intervention: R-CHOP (standard treatment)
Number of subjects: 109
Study: 20633187

Group type: EXPERIMENTAL
Intervention: Rabeprazole-based quadruple rescue therapies (RB)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Esomeprazole-based quadruple rescue therapies (EB)
Number of subjects: 190
Study: 18230233

Group type: EXPERIMENTAL
Intervention: Written emotional disclosure (ED)
Number of subjects: 0
Study: 16634502

Group type: EXPERIMENTAL
Intervention: Flapless procedure
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open-flap procedure
Number of subjects: 60
Study: 14594023

Group type: EXPERIMENTAL
Intervention: Leading questions approach
Number of subjects: 595

Group type: COMPARATOR
Intervention: Neutral questions approach
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: Scales incorporating degree of difficulty
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: All four approaches (leading, neutral, degree of difficulty, counts of tasks)
Number of subjects: 595
Study: 10857840

Group type: EXPERIMENTAL
Intervention: 0.005% latanoprost once daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: 0.5% timolol twice daily
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Comparison of latanoprost and timolol
Number of subjects: 32
Study: 2302935

Group type: EXPERIMENTAL
Intervention: Adrenaline infusion
Number of subjects: 19

Group type: COMPARATOR
Intervention: Mental stress (CWT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 19
Study: 6994783

Group type: EXPERIMENTAL
Intervention: Guanfacine 1.0 mg and 2.0 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Clonidine 0.15 mg and 0.3 mg
Number of subjects: 24